Results 241 to 250 of about 71,642 (287)

The pharmacokinetics of midazolam in man

open access: yesEuropean Journal of Clinical Pharmacology, 1981
Midazolam, a new water-soluble benzodiazepine, was administered as: i) 5 mg intravenously, ii) a 10-mg oral solution and iii) a 10-mg oral tablet, to six volunteers whose informed consent had been obtained.
Maree T Smith, Smith M T, Eadie M J
exaly   +2 more sources

Midazolam kinetics

Clinical Pharmacology and Therapeutics, 1981
The effect-kinetics of the new benzodiazepine midazolam was evaluated in six subjects after single oral (7.5 and 15 mg) and intravenous (0.075 mg/kg) doses and infusion programs. The drug is bound to plasma proteins by 94%, and less than 0.5% is excreted unchanged in urine.
H, Allonen, G, Ziegler, U, Klotz
openaire   +2 more sources

Intramuscular midazolam.

Anaesthesia, 1983
Summary Midazolam, administered intramuscularly was compared with papaveretum and hyoscine for premedication in patients undergoing gynaecological surgery. Midazolam proved to be a satisfactory agent for premedication compared with papaveretum and hyoscine, producing a similar degree of sedation and anxiolysis, but causing ...
E J, McAteer, J, Dixon, J G, Whitwam
openaire   +2 more sources

Midazolam

Anesthesiology, 1985
Midazolam is an imidazobenzodiazepine with unique properties when compared with other benzodiazepines. It is water soluble in its acid formulation but is highly lipid soluble in vivo. Midazolam also has a relatively rapid onset of action and high metabolic clearance when compared with other benzodiazepines. The drug produces reliable hypnosis, amnesia,
J. G. Reves   +3 more
openaire   +1 more source

Midazolam or No Midazolam

Critical Care Medicine, 1999
Paul Marik, Joseph Varon
openaire   +2 more sources

Intranasal midazolam

Emergency Medicine Journal, 2009
R, Owen, N, Castle
openaire   +2 more sources

The article on midazolam

Critical Care Nurse, 1994
M, Danish, C, Ross
openaire   +2 more sources

Home - About - Disclaimer - Privacy